120 Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
61
- Portfolio
-
28
- Exits
-
33
120 Capital General Information
Company Description
120 Capital is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in life sciences and healthcare sector startups.
Business Details
Website
www.120capital.comInvestor Status
Primary Investor Type
Corporate Office
- 800 Boylston Street
- Suite 410 Prudential Center
- Boston, MA 02199
- United States
120 Capital Investments (61)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Dewpoint Therapeutics | 13-Jul-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Parabilis Medicines | 23-Jan-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| VFLO Medical | 03-Dec-2024 | Medical Supplies | Generating Revenue | |||
| Joint Venture (Inari Medical / 6 Dimensions Capital / VFLO Medical / 120 Capital) | 02-Dec-2024 | Medical Supplies | Generating Revenue | |||
| Sironax | 13-Sep-2024 | Drug Discovery | Clinical Trials - General | |||
| Halda Therapeutics | 31-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Ultivue | 25-Jul-2024 | Other Healthcare Technology Systems | Generating Revenue | |||
| Neuspera | 18-Jun-2024 | Therapeutic Devices | Generating Revenue | |||
| Centrexion Therapeutics | 27-Nov-2023 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Engine Biosciences | 31-Oct-2023 | Later Stage VC | Drug Discovery | Clinical Trials - General |
120 Capital Exits (33)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Parabilis Medicines | 10-Jun-2026 | IPO | |
| Immunitas Therapeutics | 12-May-2026 | ||
| Medeor Therapeutics | 01-Feb-2026 | ||
| Halda Therapeutics | 26-Dec-2025 | ||
| iTeos Therapeutics | 29-Aug-2025 | ||
| Ultivue | 09-Oct-2024 | ||
| Refuge Biotech | 03-Aug-2023 | ||
| Cutia Therapeutics | 09-Jun-2023 | ||
| AltheaDx | 26-Apr-2022 | Merger/Acquisition | |
| GRAIL | 18-Aug-2021 | Merger/Acquisition |
120 Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
120 Capital Investments by Industry, Year, and Region
120 Capital Co-Investors (63)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Invus (Private Equity) | 3 |
|
|
||
| ARCH Venture Partners |
|
|
|||
| Fidelity Management & Research Company |
|
|
|||
| GV |
|
|
|||
| RA Capital Management |
|
|
120 Capital FAQs
-
What is 120 Capital?
120 Capital is a venture capital firm based in Boston, Massachusetts.
-
Where is 120 Capital headquartered?
120 Capital is headquartered in Boston, MA.
-
What is 120 Capital's total asset value?
120 Capital has around in total assets under management.
-
How many investments has 120 Capital made?
120 Capital has made 61 investments.
-
What has 120 Capital invested in?
120 Capital has made numerous investments in companies like Dewpoint Therapeutics, Parabilis Medicines, and VFLO Medical within the Drug Discovery and Medical Supplies industries.
-
What has 120 Capital invested in recently?
120 Capital's latest investment was on 13-Jul-2026 in Dewpoint Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process